PRO: Patients with recurrent ovarian cancer should be treated with antiangiogenic agents in combination with chemotherapy

Academic Article

Digital Object Identifier (doi)

Author List

  • Boruta D; Farley J; Birrer MJ
  • Start Page

  • 70
  • End Page

  • 73
  • Volume

  • 4
  • Issue

  • 2